Active Ingredient: OLAPARIB
Proprietary Name: LYNPARZA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N208558
Product Number: 002
Approval Date: Aug 17, 2017
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:
Prescription
Patent and Exclusivity Information
